Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: Centennial III/IV

Description

iopharma as an industry has been rapidly growing with the development and demonstration of new engineered cell and gene therapies. However, amit is becoming increasingly recognized that many of these existing or prospective therapies could be far more efficacious, reliable, and even safe if paired with the appropriate biomaterial solutions. This panel would discuss the increasing convergence of new biopharma and the fields of cell and tissue interfacing Biomaterials - realizations, challenges, and opportunities for Biomaterials to be the key to unlocking massive biopharma potential and value.

Moderator:

Adam Jakus
BioThera3 Advising & Consulting, LLC

8:00 AM. 102. Talk by Adam Jakus, Biothera3 Speakers Adam Jakus
8:00 AM. 103. Talk by Andrew Osterman, Patients Precise Speakers Andrew Osterman
8:00 AM. 104. Talk by Caroline Dugopolski, E2E Bioconsulting Speakers Caroline Dugopolski
8:00 AM. 105. Talk by Carolyn Yeago, Emory University Speakers Carolyn Yeago

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: Centennial I

Description

There are increasing demands for orthopedic biomaterials which play critical roles in patient care. This session invites presentations on metals, ceramics, and polymers that are used every day in modern orthopedic applications. Particular focuses will include octacalcium phosphates, bioabsorbable metallic materials, biomaterial degradation and impacts, and additive manufacturing. Applications will span across orthopedic, cardiovascular, craniomaxillofacial implants, etc. In vitro, in vivo, and in silico studies, as well as studies focusing on commercialization and clinical/translational challenges are welcome.

Moderators:

Marcin Wekwejt
Research Assistant Professor
Gdansk University of Technology

Dr. Amandine Impergre
Research Assistant Professor
Cloemson University

8:00 AM. 106. Composite 3D Printed Resorbable Scaffolds Support Rapid Bone Regeneration in Sheep Critical Size Bone Defects.Gerardo Figueroa Romero1, Gabriela Maldonado1, Stephany Maldonado1, David Gonzales1, Lilly . Pepe1, Luis Arciniaga1, John Szivek, PhD1, David Margolis, MD, PhD1 1University of Arizona
8:15 AM. 107. Biodegradable Poly(caprolactone)/Poly(silyl fumarate) Shape Memory Scaffolds. Jenlyan Negron Hernandez1, Kaley Beach1, Paola Chavarria1, Melissa Grunlan, Ph.D.1 1Texas A&M University
8:30 AM. 108. In Situ Printing-Enabled Fixation for Personalized Bone Defect Treatment.Feiyang Li1, Amir Seyedsalehi1, Farnoosh Saeedinejad1, Noah Pereira1, Mikaela Kutroli1, Ali Tamayol, PhD1, Mohamadmahdi Samandari, PhD2 1UConn, 2Old Dominion University
8:45 AM. 109. Investigation of hyaluronic acid-based hydrogel network formation for 3D in vitro modeling of knee meniscus.Kyley Burkey1, Yiwen Zheng2, Kinsey Drake2, Ryan Brady2, Cole Deforest, PhD2, Alshakim Nelson, PhD2, Aniruddh Vashisth, PhD2, Jenny Robinson, Ph.D.2 1University of Kansas, 2University of Washington
9:00 AM. 110. Bioprinted Collagen Scaffolds with TGF-β3 Delivery for Enhanced Fibrocartilage Differentiation.Chris Bashur, PhD1, Emily Matheson1, Victor Nygaard1, Shirin Changizi, PhD1, Nashaita Patrawalla, PhD1, Vipuil Kishore1 1Florida Institute of Technology
9:15 AM. 111. Hybrid Chitosan/PCL Shape Memory Scaffolds with Potential for Bone Regeneration and Infection Resistance.Damion Dixon, Ph.D.1, Ainsley Shields, N/A1, Shane Stafslien, N/A2, Lyndsi Vander Wal, N/A3, Melissa Grunlan, Ph.D.1 1Texas A&M University, 2North Dakota State University, 3North Dakota State Unniversity
9:30 AM. 112. Electrospun Fiber Surface Roughness Directs Human Macrophage Phenotype and Enhances Meniscus Regeneration.KaLia Burnette, BS1, Hubert Tse, PhD1, Bryan Jandres, BS2, Samuel Hurt, BS3, Aidan Alemifar, PhD2, Jenny Robinson, Ph.D.2 1University of Kansas Medical Center, 2University of Washington, 3University of Kansas
9:45 AM. 113. Tanfloc-functionalization of Titania Nanotubes to Improve Hemocompatibility and Minimize Biofilm Formation.Vignesh Sathyanarayanan, G015022571, Ramesh Singh1, Liszt Madruga1, Ketul Popat1 1George Mason University

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Description

This session will survey the diverse range of contemporary drug delivery systems and innovations. Drug delivering biomaterials can include nanoparticles, hydrogels, nanofibers, cell and virus-derived particles, or bioconjugates. Payloads can include DNA, RNA, antibodies, recombinant proteins, or small molecules. Disease applications can range from neurodegeneration to autoimmune disease, trauma, infection, or cancer. Work at all scales, from basic formulation science through therapeutic application in disease models is welcome. Studies that critically evaluate the impact of injection route on treatment efficacy and/or use novel imaging modalities to evaluate drug delivery performance are especially encouraged.

Moderators:

Dr. Aliasger Salem
Lyle and Sharon Bighley Endowed Chair & Professor / Associate Vice President for Research
University of Iowa, College of Pharmacy

John Martin
Assistant Professor
University of Cincinnati

Dr. Christine Wang
Assistant Professor of Materials Science and Engineering
Northwestern

8:00 AM. 114. Chemically modified RNA activated scaffolds enhance bone regeneration.Aliasger Salem, PhD1 1University of Iowa
8:15 AM. 115. Bone-targeted nanoparticles accelerate fracture healing in aged mice.Vigneshkumar Rangasami, PhD1, Danielle Benoit1 1University of Oregon
8:30 AM. 116. Hyaluronic Acid Microgels for Controlled Decorin Delivery To Reduce Upper Airway Fibrosis.Yashna Gupta1, Ryan Friedman, PhD1, Elizabeth Brown, MS2, Hannah Bonelli1, Matthew Aronson, PhD1, Kendra McDaid, BS, CVT, RLAT3, Karen Zur, MD3, Riccardo Gottardi, PhD1 1University of Pennsylvania, 2Stanford University, 3Children's Hospital of Philadelphia
8:45 AM. 117. Hydrogel-based approach for localized delivery of cardiac-specific gene therapy.Gabriella Kabboul, B.S.1, Luiza DaMotta, B.S.2, Lanfang Wang, M.S.3, Christopher Doering, PhD3, Andrés García, PhD2, Rebecca Levit, MD3 1Georgia Institute of Technology and Emory University, 2Georgia Institute of Technology, 3Emory University
9:00 AM. 118. Inflammation-responsive antibiotic coatings for prophylactic bacterial infection treatment in orthopedic reconstructions.Karina Bruce1, Dylan Marques1, Halle Tisovic1, Jacob Ryan1, Rais fataki1, David Wendell, PhD1, John Martin, PhD1 1University of Cincinnati
9:15 AM. 119. Super-Lubricious Platelet-Rich Plasma Loaded Microgels for the Treatment of Knee Osteoarthritis.Samuel Stealey, PhD1, Yousef Abu-amer, PhD2, Silviya Zustiak, PhD1 1Saint Louis University, 2Washington University in St. Louis
9:30 AM. 120. Nano-in-Microgel Combination Drug Delivery Platform for Localized Prolonged Immunomodulation to Prevent Allograft Rejection in Extrahepatic Islet Transplantation.Dhanashree Surve1, Chris Li2, Grisell Gonzalez3, Ana Hernandez3, Peter Buchwald4, Alice Tomei3 1University of Miami, 2Unviersity of Miami, 3University of Miami, Diabetes Research Institute, 4Diabetes Research Institute, University of Miami
9:45 AM. 121. Ingestible molecular probes for breath-based monitoring of microbiome drug metabolism.Vishal Manickam, BS1, Carly Kimpling, BS1, Khoi Le, BS1, Madeleine Troussé, BS1, Amy Kang, BS1, Aarsh Patel, BS1, Leslie Chan, PhD1 1Georgia Institute of Technology

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: Hanover AB

Description

This session will explore cutting-edge biomaterials that advance islet and beta cell transplantation for type 1 diabetes by addressing cell manufacturing, immune rejection, hypoxia, inflammation, engraftment, vascularization, and retrievability. Biomaterial strategies include immunomodulatory materials, encapsulation systems, and scaffolds that enhance cell survival, function, and transplantation outcomes. Discussion will cover the path to commercialization, including regulatory considerations, translational hurdles, and emerging market opportunities.

Moderators:

Edward Phleps
Associate Professor
J. Crayton Pruitt Family Department of Biomedical Engineering

Jessica Weaver
Principal Invesitgator
Arizona State University

Alan Chiu
Research Scientist
Breakthrough T1D

8:00 AM. 122. 4D Extracellular Matrix Platform Models Human Cytotoxic T Cell Interactions with β-cells in Type 1 Diabetes.Magdalena Samojlik1, Min Du, M.S.1, Austin Kratz, B.S.1, Matthew Brown1, Todd Brusko1, Edward Phelps1, Holger Russ1, Cherie Stabler1 1University of Florida
8:15 AM. 123. Vascularizing Hydrogel to Deliver Stem Cell-Derived Islets to the Subcutaneous Space.Angelica Torres1, Sophia Kioulaphides, B.S., M.S.1, Graham Barber, Research Technician1, Haval Shirwan, Professor2, Esma Yolcu2, Ji Lei, Professor3, James Markmann, Professor3, Jeffrey Millman, Professor4, Andrés García, PhD1 1Georgia Institute of Technology, 2University of Missouri, 3University of Pennsylvania, 4Washington University, St. Louis
8:30 AM. 124. Kinetics of immune responses toward macroencapsulated allogeneic insulin secreting cell grafts in leading transplant sites.Tuhfah Norris, MS1, Tanush Varma1, , Matthew Becker, PhD1, Jessica Weaver, Ph.D.1 1Arizona State University
8:45 AM. 125. Immunomodulatory microporous annealed particle hydrogel scaffolds to prevent allogeneic islet rejection and facilitate vascularization in extrahepatic sites.Christopher Spencer, MS1, Adrienne Widener1, Cameron Manson1, Jessie Barra1, Holger Russ1, Edward Phelps1 1University of Florida
9:00 AM. 126. Dual-Targeting Lipid Nanoparticles for Gene Delivery to Pancreatic β Cells.Di Yu1, Yining Zhu, PhD1, Leonardo Cheng1, Gene Weng1, Arturo Roca-Rivada, PhD2, Decio Eizirik, PhD2, Hai-Quan Mao, PhD1 1Johns Hopkins University, 2Université Libre de Bruxelles
9:15 AM. 127. Discovering Core Immunobiology in Indirect Rejection of Encapsulated Islet Grafts for Type 1 Diabetes Treatment.Victor Quiroz, B.A.1, Alexandra Gorham, B.A.1, Joshua Doloff, Ph.D.1 1Johns Hopkins University
9:30 AM. 128. Modulating PD-L1 Presentation through Polymer Chain Length to Drive T Cell Tolerance in Islet Transplantation.Nicole Racca1, Jinhua Sun1, Jean-Pierre Pierantoni1, Esma Yolcu2, Haval Shirwan, Professor2, Maria Coronel, PhD1 1University of Michigan, 2University of Missouri
9:45 AM. 129. Engineering FRESH 3D Bioprinted Islet-Like Constructs with Immunomodulatory Cell Factories.Ezgi Bakirci1, Katrin Vilinsky1, Cassidy Hart, MD2, Dilrasbonu Vohidova2, Andrew R Hudson1, Daniel Shiwarski, PhD3, Omid Veiseh, PhD2, Adam W. Feinberg, PhD1 1Carnegie Mellon University, 2Rice University, 3University of Pittsburgh

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: Hanover CDE

Description

Tissue Engineering SIG is a forum to exchange information, further knowledge, and promote greater awareness regarding all aspects of the use of biomaterials to engineering tissue substitutes or to promote tissue regeneration. Of primary interest and relevance to TE SIG is the use of appropriate materials (synthetic and natural) with cells (either native or from a donor source) and/or biological response modifiers (e.g., growth factors, cytokines and other recombinant products) to replace tissue and organ functions. Particular emphasis is placed on the
development of materials to better incorporate, protect, and deliver both the cells and biological response modifiers to help promote the healing and regenerative processes. This year’s session will also highlight the latest advancements in naturally-derived biomaterials, bioadhesives, and biomaterial membranes for tissue repair and wound healing. The group is committed to forging interactions among basic scientists, applied scientists, engineers, clinicians, industrial members,
professional societies in related fields, and regulatory groups in its efforts to expand and effectively utilize the shared knowledge base in this multidisciplinary field. This session will also include biomaterials-enabled organoid systems and integrated biomaterials and synthetic biology approaches to engineer, model, and regenerate functional tissues.

Moderators:

Muhammad Rizwan
Assistant Professor | Department of Biomedical Engineering | Ophthalmology
UT Southwestern Medical Center

Woojin Han
Associate Professor | Orthopedics, Orthopedic Research
Associate Professor | Stem Cell Biology And Regenerative Medicine
Icahn School of Medicine at Mount Sinai

Jessica Gluck
Assistant Professor
North Carolina State University

Mai Ngo
University of Wisconsin-Madison

Seth McCullen
Poly-Med

8:00 AM. 130. Translation of Precision Porous Scaffolds from Laboratory to the Clinic.Buddy Ratner, Ph.D.1 1University of Washington
8:15 AM. 131. Chemically Crosslinked Decellularized Matrix Hydrogels for Generating Functional Pancreatic Duct-Like Organoids.Ngoc Ha Luong, PhD1, Van Thuy Duong, PhD1, Chien-Chi Lin, PhD1 1Purdue University
8:30 AM. 132. Unconventional Biomaterials for Enhancing Tissue Engineering and Regenerative Medicine.Gulden Camci-Unal, PhD1 1University of Massachusetts Lowell
8:45 AM. 133. 3D Human Pluripotent Stem Cell Differentiation to Study Thalidomide-Induced Congenital Heart Defects.Morgan Ellis, Ph.D.1, Ferdous Finklea, Ph.D.1, Petra Kerscher, Ph.D.1, Lauren Black, Ph.D.2, Elizabeth Lipke1 1Auburn University, 2Tufts University
9:00 AM. 134. Mechanically Resilient and Bioactive Ear Scaffolds.Na Huang1, Shui Kwong John Lee1, Kenneth Ka Ho Lee2, Chunyi Wen3, Yun Chang3, Ming Zhang3, Cheng Dong3, Chuanbin Mao1, Dan Michelle Wang1, Elmer Dai Fei Ker3 1The Chinese University of Hong Kong, 2Occam Biosciences, Scotland, 3The Hong Kong Polytechnic University
9:15 AM. 135. Proteomics of Decellularized Axolotl Tissues: Impact of Preparation Methods on Composition.Jasmine McTyer1, Sarah Newcomb1, Kaylie Verkon1, Dylan Turpeinen, PhD2, Whitney Stoppel, PhD1 1University of Florida, 2NeXtGen Biologics
9:30 AM. 136. Wavelength-regulated cell-based biohybrid patch for temporal immunomodulation of the wound bed.Elizabeth Kelley1, Matthew Parker1, Liyang Wang2, Alvaro Moreno Lozano1, Kalina Peneva1, London Frey1, Jonathan Rivnay, PhD3, Tzahi Cohen-Karni, PhD2, Jacob Robinson, PhD1, Christian Schreib, PhD1, Omid Veiseh, PhD1 1Rice University, 2Carnegie Mellon University, 3Northwestern University
9:45 AM. 137. Photo-Tunable Materials Reveal Dynamic Role of YAP Mechanotransduction During Intestinal Crypt Formation.Nolan Petrich, B.S.1, Kaustav Bera, Ph.D.1, Delaney McNally, B.S.1, Peter Dempsey, Ph.D.2, Kristi Anseth3 1University of Colorado Boulder, 2University of Colorado Anschutz Medical Campus, 3University of Colorado at Boulder

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: Hanover FG

Description

Technologies for 3D printing and biofabrication are rapidly advancing and poised to transform the way we study human development and treat human disease. To realize their immense potential, we need new bioink materials that have not only the appropriate properties for cell culture, but also the required properties for biofabrication, which can vary drastically depending on the selected technology. This session invites experimental and theoretical studies of innovative bioink design, including to benchmark and standardize new bioinks, strategies to customize bioinks for clinical applications, and approaches to validate bioinks for platforms such as drug discovery and toxicology.

8:00 AM. 138. Talk by Jason Burdick, University of Colorado Boulder Speakers Prof. Jason Burdick
8:30 AM. 139. Stereocomplexed Hydrogel Microparticles as Building Blocks for Bioprinting.Bridget Linders1, Meagan Arguien1, Gianna Tutoni1, Matthew Bonacci1, Matthew Becker, PhD1 1Duke University
8:45 AM. 140. Bioprinted Model of Myocardial Infarction with Chromogenic Force Sensors as In-Situ Probes for Spatial Heterogeneity.Natalie Celt, B.S.1, Yuyao Kuang, B.S., M.S., Ph.D.1, Herdeline Ardoña, B.S., Ph.D.1 1University of California, Irvine
9:00 AM. 141. 3D Printing Initiator-Functionalized Polymer Conjugates to Fabricate Scaffolds with Surface-Grafted Bottlebrushes.Diana Hammerstone, PhD1, F. Gerardo Ortega Oviedo, B.S.1, Matthew O'Connell1, Santiago Lazarte, B.S.2, D. Christopher Radford, PhD3, Adam Gormley, Ph.D.4, Brandon Krick, PhD2, Lesley Chow1 1Lehigh University, 2Florida State University, 3Rutgers University, 4Rutgers University, New Brunswick
9:15 AM. 142. In situ rheological monitoring of diffusion-controlled hydrogel crosslinking for embedded 3D bioprinting.Audrey Shih1, Fotis Christakopoulos, PhD1, Stella Chung1, Lucia Brunel, PhD1, Noah Eckman1, Yueming Liu1, Junyi Tao2, Sarah Heilshorn, PhD1, Gerald Fuller, PhD1 1Stanford University, 2University of Tokyo
9:30 AM. 143. Oxidation-Degradable Resins for 3D Printing of Cell-Responsive Biomaterials.John Martin, Ph.D.1 1University of Cincinnati
9:45 AM. 144. Single-network, viscoelastic bioink with static and dynamic covalent bonds enhances stability for 3D cell culture.Renato Navarro, PhD1, Michelle Huang2, Narelli de Paiva Narciso2, Lucia Brunel, PhD2, Neil Baugh2, Sarah Heilshorn, PhD2 1University of Florida, 2Stanford University

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: GH East AB

Description

Computational modeling and machine learning can enhance our ability to design and evaluate biomaterials for a variety of applications. Artificial intelligence has also been playing an increasingly important role in the development of biomaterials and in disease treatment. This session will explore computational approaches and machine learning/artificial intelligence tools for designing and classifying biomaterials for tissue engineering and other applications, evaluating complex data from in vitro and in vivo studies, and predicting biomaterial performance in different microenvironments. Examples of these may include fluid mechanics and bio-transport models of drug/protein delivery, models of protein-protein and protein-material interactions, statistical modeling for biomaterial optimization, machine learning for biomaterial design and analysis, and bioinformatics-based platforms for analyzing complex data, including RNA sequencing and other -omics approaches. Progress and challenges in applying artificial intelligence in developing biomaterials and in disease treatment will also be discussed.

Moderators:

Adam Gormley
Associate Professor | Biomedical Engineering
Rutgers

8:00 AM. 145. AI-Powered Peptide Engineering: Design, Classify, and Validate Innovative Therapeutic Peptides.Bingyun Li, PhD1, Alexa Sowers, PhD2 1West Virginia University School of Medicine, 2West Virginia University
8:15 AM. 146. Direct Mapping of Extracellular Matrix Architecture to Cellular Communities in Lung Disease.Jason Guo, Ph.D.1, Georgios Mikos, B.S.1, Michelle Griffin, M.D., Ph.D.1, Jung-Ki Yoon, M.D., Ph.D.1, Shamik Mascharak, M.D., Ph.D.1, Derrick Wan, M.D., F.A.C.S.1, Paul Wolters, M.D.2, Tushar Desai, M.D.1, Michael Longaker, M.D., M.B.A., F.A.C.S.1 1Stanford University, 2University of California, San Francisco
8:30 AM. 147. From Aggregation to Architecture: Mapping Peptide Self-Assembly.Shimanto Roy, B.Sc, M.Eng1, Kyle Lampe, PhD1, Camille Bilodeau, PhD1 1University of Virginia
8:45 AM. 148. Applying computational protein design to engineer VEGF- and PDGF-specific affinity-controlled delivery systems.Justin Svendsen, Student1, Chandler Asnes, B.S.1, Madeleine Ford, B.S.1, Simon Oh, B.S.1, Parisa Hosseinzadeh, Ph.D.1, Michael Harms, Ph.D.1, Marian Hettiaratchi, Ph.D.2 1University of Oregon, 2University of Oregon Knight Campus
9:00 AM. 149. Generative Adversarial Networks to Profile Structure-Function Correlation of Human iPSC-Derived Cardiomyocytes.Andrew Kowalzewski, MS1, Huaxiao Yang, PhD.2, Zhen Ma, Ph.D1 1Syracuse University, 2University of North Texas
9:15 AM. 150. Data-Driven Design of Protein-like Polymer Nanoparticles.Elena Di Mare, ME1, Cesar Ramirez, PhD1, N. Sanjeeva Murthy1, Adam Gormley, Ph.D.2 1Rutgers University, 2Rutgers University, New Brunswick
9:30 AM. 151. Inferring Local Mechanics of Native Cardiovascular Tissue in 3 Dimensions via Machine Learning from Co-Registered Polarization-Resolved Second Harmonic Generation and Atomic Force Microscopy
9:45 AM. 152. A Deep Learning-Based Multi-Donor Voting Platform to Evaluate Large-Scale Drug-Induced Cardiotoxicity.Danny Vu, BS1, Andrew Kowalzewski, MS1, Zhen Ma, Ph.D1 1Syracuse University

Date: Thursday, March 26, 2026
Time: 8:00 AM to 10:00 AM

Room: GH East CD

Description

Over the past decade the focus of many bioengineers and clinicians has been shifting towards "immune engineering" approaches that include but are not limited to engineered biomaterials for vaccines, immunotherapy (immune-modulation), cell and gene therapy, immune microenvironment engineering, and systems immunology. These research areas embrace a comprehensive list of translational immunology-associated problems including chronic infections, autoimmune diseases, aggressive cancers, allergies, etc. The purpose of the Immune Engineering SIG is to bring together emerging ideas and provide a venue for professional interaction to a large number of academic and industrial research groups and scientists working in these areas.

Moderators:

Michelle Teplensky
Assistant Professor of Biomedical Engineering
Boston University

Dr. Abhinav Acharya
Associate Chair for Research, Department of Biomedical Engineering
Case Western reserve University

8:00 AM. 153. Engineering the Immune Interface: A high-throughput platform for discovery of surface topographies that tune macrophage polarization in vitro and in vivo.Sudip Chakraborty1, Connor Edvall1, Pamela Allison Manco Urbina1, Adelmo Lopez2, Suman Bose, Ph.D.1 1Mayo Clinic, 2University of Michigan
8:15 AM. 154. Effects of Poly(β-amino ester) Networks on Macrophage Response In Vitro.Kayla Castillo-Aguilar, BS in Chemical Engineering1, Aiden Walter2, Stephanie Bryant, PhD3 1University of Colorado Boulder, 2Rose-Hulman Institute of Technology, 3Univeristy of Colorado - Boulder
8:30 AM. 155. CD45-Targeted IL-12 Drives a Multiepitope T Cell Response for Enhanced Lung Cancer Immunotherapy.Brett Pogostin, PhD1, Vidit Bhandarkar, PhD1, Olivia Sheridan, BS1, Sean-Luc Shanahan, BS1, Robert Langer2, Ana Jaklenec2, Darrell Irvine, PhD3, Stefani Spranger, PhD1 1MIT, 2Massachusetts Institute of Technology, 3Scripps Research Institute
8:45 AM. 156. Engineering Self-Therapeutic Nanoscale Hydrogels: Activity and Biodistribution Evaluation in Mice.John Clegg, PhD1, Mojtaba Ghanbari Mehrabani, MS1, Harsh Joshi, PhD1, Abigail Kauten1, Rana Ajeeb, PhD1 1University of Oklahoma
9:00 AM. 157. Modular Noncovalent Functionalization of Electrospun Piezoelectric Scaffolds with Bioactive Nanocarriers.Sarah Bortel, MS1, Sumayia Chowdhury, MS1, Jeremy Cheng, MS1, Daniella Uvaldo1, Mackenzie Wright1, Santiago Correa1, Treena Livingston Arinzeh, PhD1 1Columbia University
9:15 AM. 158. Systemically Administered Cd14 siRNA Lipid Nanoparticles Mitigate the Inflammatory Response to Intracortical Microelectrode Implants.Francine Graham, BSc1, Diarmuid Hutchinson, BSc1, Jeffrey Capadona, PhD2, Efstathios Karathanasis, PhD1 1Case Western Reserve University, 2Case Western Reserve University/Louis Stokes Cleveland Department of Veterans Affairs Medical Center
9:30 AM. 159. Mechanical Cues Shape Immunomodulation: Matrix Stress-Relaxation Modulates Macrophage Phenotype in 3D Brain-Mimicking Hydrogels.Audrey Jung, Undergraduate Student1, Mark Fleck, PhD Student1, Sauradeep Sinha, PhD2, Abena Peasah, PhD Student1, Fan Yang, PhD1 1Stanford University, 2St. Jude Children's Research Hospital
9:45 AM. 160. Smartphone-Guided Visible Light Modulation of RSNOs for Antimicrobial Activity via Controlled Nitric Oxide Release.Alexander Bruckmann, M. S.1, Adam Goodman1, Mark Garren, Ph.D.1, Elizabeth Brisbois, Ph.D.1, Hitesh Handa, Ph.D.1 1University of Georgia

3A: PANEL: Biomaterials & Regenerative Medicine - The Solution to Enabling New Biopharma Technologies and Products?

Description

3B: Orthopaedic Biomaterials SIG

Description

3C: Drug Delivery SIG 1: Smart Biomaterials for Therapy, Regeneration, and Sensing

Description

3D: Biomaterials for Islet Cell Therapy - From Innovation to Commercialization

Description

3E: Tissue Engineering SIG 1

Description

3F: Designing Biomaterials for Use as Bio-Inks

Description

3G: Computational, Machine Learning, and Artificial Intelligence Approaches in Biomaterials

Description

3H: Immune Engineering SIG 1

Description